Fact-checked by Grok 2 weeks ago

Wart

A wart is a benign, noncancerous growth caused by with one or more strains of the human papillomavirus (HPV), a DNA virus that infects the epithelial layers of and mucous membranes. Over 200 subtypes of HPV have been identified, with specific types responsible for different wart presentations, such as types 2 and 4 for common warts on the hands and feet. These growths are typically small, rough, and painless but can vary in appearance and location, often resolving spontaneously within two years without treatment, though recurrence is common. Warts affect approximately 10% of the general , with higher among school-aged children (10-20%), individuals with weakened immune systems, and those in occupations involving frequent , such as meat handlers. They spread through direct skin-to-skin contact or indirectly via contaminated surfaces, thriving in moist environments like public showers or pools, and are more common in fair-skinned individuals. Common types include common warts (verruca ), which appear as raised, grainy lesions with black dots on fingers or hands; plantar warts on the soles of the feet, which can be painful due to pressure; (verruca plana), smooth and slightly elevated on the face or legs; and (condyloma acuminata), caused by low-risk HPV types like 6 and 11, appearing as soft, cauliflower-like growths in the genital or anal areas. Less common variants include filiform warts (thread-like on the face) and warts (clustered plantar types). Most warts are and pose no serious health risk, though they may cause cosmetic concerns, itching, or discomfort, particularly if located on areas like the feet. is primarily clinical based on appearance and , with or HPV testing reserved for atypical or persistent cases to rule out , particularly in immunocompromised patients where such lesions may be associated with oncogenic HPV types (primarily in genital areas) or recent findings (as of 2025) indicating that cutaneous beta-HPV types can contribute to . Treatment is often pursued for symptomatic or persistent warts and includes topical (with cure rates of 50-70%), using , , , or , though about two-thirds of warts resolve without intervention. Prevention focuses on avoiding direct with warts, keeping dry and intact, using protective in communal areas, and vaccination against high-risk HPV types (e.g., via the , which also reduces incidence).

Types

Common Warts

Common warts, also known as verruca vulgaris, present as rough, dome-shaped, hyperkeratotic papules that typically measure 1-10 mm in diameter. These growths often exhibit a grainy or verrucous surface texture and are commonly flesh-colored or grayish in hue, sometimes featuring small black dots within the lesion that correspond to thrombosed capillaries. They are primarily caused by human papillomavirus (HPV) types 2 and 4, with self-inoculation through minor trauma leading to the formation of clusters on the hands. Common locations include the hands, fingers, knees, and elbows, where the lesions tend to develop on exposed or frequently traumatized . These warts are more prevalent among children and individuals with immunocompromised states. Distinguishing common warts from calluses or corns relies on clinical examination, as warts disrupt the normal continuity of lines (), whereas calluses and corns preserve these lines within the . This feature, along with the presence of thrombosed capillaries, aids in accurate without invasive procedures.

Plantar Warts

Plantar warts, also known as verruca plantaris, are benign growths that develop on the surfaces of the feet, characterized by their hard, thickened appearance due to from mechanical pressure. These warts typically present as rough, callus-like with disrupted lines, often featuring small black dots in the center that represent thrombosed capillaries. Unlike other wart types, their location on the soles exposes them to constant and , leading to inward growth and a flattened profile surrounded by a thickened rim of hardened . These growths commonly occur on the soles, heels, and balls of the toes, where pressure is greatest during walking or standing, and they may cluster into mosaic warts—tight groupings of multiple small, flat warts that cover a larger area. The painful nature of plantar warts stems from this mechanical stress, as the lesions press against underlying nerves and tissues, causing discomfort that intensifies with each step; in severe cases, they can lead to limping or bleeding if traumatized. Single, deeper lesions known as myrmecia are particularly tender due to their conical shape penetrating the skin. Plantar warts are caused by specific strains of the human papillomavirus (HPV), primarily types 1, 2, and 4, which infect through minor cuts or abrasions. These viruses thrive in warm, moist environments, resulting in higher incidence around public swimming pools, locker rooms, and communal showers, where exposure facilitates . Preventive measures, such as wearing protective footwear in these settings, can reduce risk, though the infection often remains dormant until triggered by pressure or trauma. A key distinction from corns or calluses lies in their vascular nature: paring down a reveals pinpoint bleeding and the characteristic , whereas corns show uniform, dry without vascular elements. This diagnostic feature, confirmed through gentle scraping, helps differentiate the viral etiology of warts from the frictional response seen in corns.

Flat Warts

Flat warts, also known as plane warts, are characterized by their smooth, flat-topped papules that measure 1-5 mm in diameter and are only slightly elevated above the surrounding . These lesions typically exhibit a -colored, pink, light brown, or yellowish hue, blending subtly with the skin tone, which often leads to them being overlooked until they multiply. They frequently appear in clusters numbering from 20 to 100, forming widespread but minimally raised groups that distinguish them from the more prominent, bulky elevations seen in common warts on the hands. These warts commonly affect the face, especially in children, where they may cluster due to minor or scratching. In adults, they often emerge on the legs or arms, particularly following or that facilitates autoinoculation and spread along the skin. Unlike , flat warts occur on non-mucosal, cutaneous sites without sexual transmission. Flat warts are primarily caused by human papillomavirus (HPV) types 3, 10, and 28, which induce epidermal in a manner that results in their subtle profile. They are more prevalent among adolescents and young adults, potentially linked to variations in that allow for lesion multiplicity. A variation of the can lead to linear arrangements of these warts along lines of skin trauma, such as from scratching or shaving.

Filiform Warts

Filiform warts, also known as digitate or facial warts, are distinguished by their elongated, thread-like or finger-like projections that protrude from the skin in a frond-like manner. These growths typically range from 1 to 2 mm in length but can extend up to 1 cm, featuring a narrow, stalk-like base with multiple fine extensions. They often appear flesh-colored but may be pigmented, presenting as brown, pink, yellow, or grayish tones that align with the surrounding skin. Their rapid development sets them apart, allowing them to emerge and elongate quickly after . These warts preferentially affect facial areas, most commonly the eyelids, , , and , where the skin is thinner and more exposed. They are more prevalent in adults, particularly men, compared to children, though they can occur on other sites like the fingers or legs through direct spread. Due to their prominent and visible locations, filiform warts frequently cause cosmetic distress, leading many affected individuals to pursue removal for appearance rather than medical necessity. Filiform warts result from infection with specific human papillomavirus (HPV) strains, primarily types 1, 2, 4, 27, and 29, which target keratinocytes in the epidermis. These non-enveloped DNA viruses gain entry through minor skin abrasions, initiating localized hyperplasia. The condition is more frequently observed in warm, humid climates, where perspiration and moisture promote viral replication and transmission via skin-to-skin contact.

Genital Warts

, also known as acuminata, are soft, moist growths that typically appear as small, skin-colored or flesh-colored bumps resembling the texture of a when clustered, or as flat plaques in some cases; their color can vary from skin-toned to reddish-brown depending on the site and individual skin type. These lesions are distinct from cutaneous warts due to their occurrence on mucosal surfaces and association with sexual transmission, often presenting as papular or pedunculated growths on the genital and perianal mucosa. They commonly develop on the , , , (including the shaft and under the ), , , , and perianal skin; internal locations such as the , , or are possible, and oral cavity involvement can occur following orogenital contact. In women, vulvar and sites are frequent, while in men, the penile shaft and are typical; perianal warts are more common in individuals engaging in receptive anal . Rarely, they may appear in the or from oral-genital contact. Genital warts are primarily caused by low-risk human papillomavirus (HPV) types 6 and 11, which account for approximately 90% of cases, though high-risk types such as HPV 16 or 18 may occasionally be involved, potentially linking to precursors of or anal cancers if undetected. These infections are sexually transmitted and carry implications for sexual health, including the need for partner notification and screening for co-infections or oncogenic strains. Most are , but they can cause itching, discomfort, or , particularly during sexual activity or if located in sensitive areas like the or . Recurrence is common, often within three months of , due to viral latency and of subclinical infections rather than new exposures, highlighting the chronic nature of HPV in the anogenital region.

Epidemiology

Prevalence and Distribution

Cutaneous warts, caused by various human papillomavirus (HPV) types, affect approximately 7–12% of the general at any given time. Prevalence is notably higher among children and adolescents, reaching up to 10–33% in school-aged groups, with incidence peaking between ages 12 and 16 years. These patterns reflect the virus's transmission dynamics in communal settings like schools, where close contact facilitates . Geographically, warts occur worldwide but show variations in distribution, with higher incidence reported in areas compared to rural ones, likely due to denser populations and increased opportunities for . Seasonal fluctuations are evident, particularly in temperate regions, where outpatient visits for warts increase during winter months, possibly linked to drier and indoor crowding. For specifically, the point prevalence among sexually active adults is around 1%, representing a visible manifestation of . Overall, approximately 80% of sexually active individuals acquire at least one over their lifetime, though the majority remain subclinical and resolve without warts. Since the introduction of HPV vaccines targeting low-risk types like HPV-6 and HPV-11, prevalence has declined substantially, with reductions of 50–90% observed in vaccinated cohorts by the 2020s; as of 2024, studies show continued reductions exceeding 80% in some populations, including decreased hospitalizations among young adults.

Risk Factors and Demographics

Warts are most prevalent among children and adolescents, particularly those aged 10 to 14 years, due to frequent skin trauma from play and shared environments such as and pools that facilitate exposure. In school-aged children, the prevalence can reach 10-33%. For specifically, incidence rates are slightly higher in males, with studies reporting medians of 137 per 100,000 in men compared to 120 per 100,000 in women, and one cohort showing 73% of cases in males. Key risk factors include , which substantially elevates susceptibility; for instance, in solid organ transplant recipients on long-term , wart prevalence rises to 50-92% after five years, representing a 50-100% higher incidence than in the general population. Similarly, individuals with or other immunosuppressive conditions experience more extensive and persistent warts due to impaired . Skin breaks from habits like or provide entry points for the , increasing infection risk in affected areas such as the hands or face. Occupational exposure heightens risk for certain groups, notably meat handlers who develop "butchers' warts" from frequent contact with contaminated by HPV type 7, with prevalence historically ranging from 8.5% to 23.8% in this profession. Genetic predispositions, such as the rare syndrome caused by in EVER1 or EVER2 genes, lead to lifelong to widespread HPV-induced warts and cancers. In the elderly, age-related immune decline () contributes to higher wart persistence and recurrence by reducing the body's ability to clear infections. Behavioral factors further modulate risk; poor hygiene practices, such as inadequate handwashing or sharing personal items, promote spread in communal settings. For , multiple sexual partners significantly increase exposure, as the virus transmits primarily through intimate contact.

Etiology

Viral Causation

Warts are exclusively caused by infection with human papillomavirus (HPV), a group of small, non-enveloped DNA viruses belonging to the family. Over 200 distinct HPV types have been identified, classified into low-risk and high-risk groups based on their potential to cause disease; benign cutaneous and mucosal warts are primarily induced by low-risk types that do not typically lead to . These viruses specifically target , the primary cells of the , where they replicate and induce hyperproliferation leading to wart formation. Cutaneous warts on non-genital are most commonly associated with HPV types 1, 2, 4, 27, and 57, while mucosal warts, such as those in the anogenital region, are predominantly caused by types 6 and 11. In contrast, high-risk HPV types like 16 and 18 possess oncogenic potential and are linked to cancers of the , , and oropharynx, but they rarely cause benign warts. No bacterial, fungal, or other non-viral pathogens are known to cause warts; all verified cases trace back to HPV infection. HPV infections can establish , persisting asymptomatically in basal for months to years without visible lesions, and may reactivate under conditions such as immune suppression or . During , the viral genome remains episomal and transcriptionally quiescent, evading host detection until triggered, which can result in recurrent or new wart outbreaks. This latent phase underscores the virus's ability to maintain long-term carriage in the host population.

Transmission Modes

Warts, caused by various strains of the , are primarily transmitted through direct skin-to-skin contact, allowing the virus to enter the body via minor cuts, abrasions, or disrupted epithelial barriers. This mode facilitates both interpersonal spread and autoinoculation, where an individual spreads the virus to other parts of their own body through activities like scratching or shaving affected areas. For common warts, transmission often occurs in close-contact settings such as schools or households, where children may unknowingly share the virus through play or shared objects, leading to outbreaks among primary schoolchildren with higher incidence linked to family and peer exposure. Plantar warts, affecting the soles of the feet, are particularly associated with environments like communal s, locker rooms, and decks, where contact with contaminated moist surfaces increases risk; studies show shower users have up to 27% prevalence compared to non-users. , in contrast, spread mainly through sexual activity, including vaginal, anal, or , as well as intimate skin-to-skin contact, with transmission rates estimated at around 4-5 per 100 person-months in heterosexual couples, though cumulative risk to partners can reach 60% over multiple encounters. The for wart development typically ranges from 3 weeks to 8 months, with most appearing 2-3 months after . Indirect transmission via fomites, such as towels, razors, or floors, is possible but less common, as HPV can survive on moist surfaces for up to several days, retaining in models for at least 7 days under damp conditions. However, the has no known animal , with humans serving as the sole natural , limiting zoonotic spread.

Pathophysiology

Viral Infection Process

The human papillomavirus (HPV) initiates infection in the basal layer of , targeting undifferentiated . Entry occurs primarily through micro-abrasions or wounds that expose the , allowing the viral capsid—composed mainly of the major L1 protein—to bind to proteoglycans on the or cell surface. This attachment facilitates into the basal , where the viral genome is uncoated and transported to the , establishing infection without immediate cell lysis. Upon nuclear entry, the circular double-stranded DNA genome persists as an extrachromosomal episome, typically at 20–100 copies per cell in the basal layer. Early viral genes, including E6 and E7, are transcribed from the early promoter, with E6 promoting degradation of p53 to inhibit apoptosis and E7 inactivating retinoblastoma protein (pRb) to drive cell cycle progression into S-phase, enabling initial low-level replication of the viral genome in synchrony with host DNA. As infected keratinocytes divide and migrate upward during epithelial differentiation, a switch to the late promoter amplifies genome copies to thousands per cell; late genes L1 and L2 are then expressed in suprabasal layers to assemble new icosahedral virions within the nucleus. Unlike lytic viruses, HPV does not destroy host cells; instead, mature virions accumulate in the granular layer and are released passively through desquamation of the uppermost cornified cells, completing the productive cycle over the ~28-day epithelial turnover without triggering overt cell death. This replication strategy induces hyperproliferation of infected keratinocytes, resulting in acanthosis (epidermal thickening due to expanded spinous layer) and hyperkeratosis (excessive keratin production in the stratum corneum), which manifest as the visible wart lesion. The full infectious cycle from entry to virion shedding aligns with host differentiation, typically spanning weeks to months for lesion development, though episomal genomes can maintain long-term persistence in basal cells for years to decades by replicating only in dividing progeny.

Host Immune Response

The human papillomavirus (HPV), responsible for cutaneous warts, employs several strategies to evade the host immune response during initial infection. Notably, HPV lacks pathogen-associated molecular patterns (PAMPs) that typically trigger innate immune detection, allowing it to infect without eliciting strong danger signals. Additionally, the viral E7 oncoprotein downregulates (MHC) class I expression on infected cells, reducing their visibility to cytotoxic T cells and facilitating persistent infection. Clearance of warts primarily relies on cell-mediated immunity, where CD4+ helper T cells, CD8+ cytotoxic T cells, and natural killer (NK) cells infiltrate the lesion to target HPV-infected keratinocytes. Cytokines such as interferon-gamma (IFN-γ), produced by these cells, play a crucial role in inducing apoptosis and limiting viral replication, leading to spontaneous regression in approximately two-thirds of cases within two years. In contrast, humoral immunity, involving B cells and antibodies, contributes minimally to wart clearance, as HPV primarily resides intracellularly and does not provoke robust antibody responses sufficient for resolution. Signs of impending regression often include localized inflammation within the wart, characterized by , swelling, and lymphocytic infiltration, which signals effective immune . However, in about one-third of cases, immune failure results in persistent warts due to inadequate T-cell responses or viral persistence. Recurrence of warts frequently stems from latent HPV reservoirs in basal , where the virus maintains low-level persistence without active replication. This risk is markedly heightened in states of , such as infection or , where impaired T-cell function allows reactivation and proliferation of latent virus.

Diagnosis

Clinical Examination

Clinical examination of warts primarily involves and simple physical maneuvers to identify characteristic features suggestive of human papillomavirus (HPV) infection, often sufficient for diagnosis in typical cases. Warts appear as well-demarcated, hyperkeratotic papules with a rough, verrucous surface, typically measuring 2-10 mm in diameter and exhibiting colors ranging from skin-toned to gray, yellow, brown, or black. A hallmark finding during is the presence of small black dots within the lesion, representing thrombosed capillaries in the papillary dermis. Dermoscopy enhances visualization, revealing dotted or linear vessels, hairpin-like structures, and bleeding spots amid papillomatous growth patterns; in some cases, a mosaic pattern of grouped vessels surrounded by white reticular networks may be observed, particularly in . Physical tests further aid in confirming the at the bedside. Paring the lesion's surface with a or exposes the black dots as pinpoint bleeding points from thrombosed vessels, distinguishing warts from similar hyperkeratotic lesions. For plantar warts, applying lateral pressure with a tongue blade elicits sharp due to involvement of deeper dermal structures, unlike the diffuse discomfort of calluses. Additionally, disruption of normal dermatoglyphic patterns ( ridges) on weight-bearing surfaces serves as a cardinal sign. Clinicians routinely inquire about the patient's history of skin trauma or exposure to shared surfaces, as warts often arise at sites of minor injury via the . Site-specific clues include linear arrangements of lesions along scratch lines or shave paths, such as on the beard area in men due to autoinoculation during grooming. Warts are most prevalent in children and young adults, where common types frequently affect the following playground injuries. In sexually active adults, may present as softer, coalescing papules in the anogenital region, prompting consideration of sexual history alongside physical findings.

Confirmatory Tests

Confirmatory tests for warts are typically reserved for cases where clinical examination yields inconclusive results, such as atypical growths, persistent lesions despite treatment, or patients with , to rule out differentials like or . serves as the gold standard for histopathological confirmation, involving either shave or techniques to obtain tissue samples for microscopic analysis. Shave biopsy is often preferred for superficial lesions, while biopsy allows deeper sampling for plantar or thicker warts. Histopathological examination reveals characteristic features including koilocytes— with perinuclear halos and pyknotic nuclei—along with acanthosis (epidermal thickening), parakeratosis (retained nuclei in the ), , and . Polymerase chain reaction (PCR) testing for HPV DNA typing provides molecular confirmation, particularly useful for or in research settings to identify specific high-risk HPV strains. This sensitive technique amplifies viral DNA from lesion swabs or biopsies, aiding in cases of or . Acetic acid whitening, involving application of 3-5% acetic acid for 5-10 minutes, highlights or flat lesions by turning HPV-infected white, enhancing visibility in genital areas but prone to false positives from conditions like . Imaging modalities are rarely employed but can assess the depth and extent of plantar warts, appearing as hypoechoic subdermal lesions with possible surrounding , guiding treatment for deeply invasive cases.

Prevention

Hygiene Practices

Maintaining personal is essential for reducing the risk of human papillomavirus (HPV) transmission that causes warts, including preventing autoinoculation where the virus spreads from one part of the body to another. Regular handwashing with and water after touching warts or potentially contaminated surfaces helps remove viral particles and lowers the likelihood of spread, as HPV can persist on and fomites. Keeping clean and dry, particularly in moist areas prone to like hands and feet, minimizes the virus's ability to enter through minor cuts or abrasions. Individuals with existing warts should cover them with bandages or waterproof plasters, especially during activities like , to limit direct contact and shedding of viral particles. Avoiding the sharing of personal items such as razors, towels, , and is a key behavioral measure to prevent indirect transmission of , as these items can harbor the even without visible blood or fluids. For periungual warts around the , proper nail care practices like keeping trimmed short and clean reduce breaks that serve as entry points for the , thereby preventing spread to adjacent areas. Biting or picking at cuticles should be avoided, as this habit facilitates autoinoculation in the region. In shared environments like pools, locker rooms, and gyms, wearing flip-flops or protective prevents direct with contaminated wet surfaces where HPV thrives. Disinfecting high-touch surfaces, such as floors or benches, with a 1:10 dilution of household () effectively inactivates HPV, as the virus is susceptible to hypochlorite-based solutions when applied for sufficient time. For caused by low-risk HPV types, consistent use during sexual activity provides partial protection by covering areas of potential transmission, though it does not eliminate risk due to skin-to-skin contact beyond the covered region. Avoiding sexual contact during active outbreaks further reduces partner transmission, emphasizing communication and until lesions resolve.

Vaccination Strategies

Vaccination strategies for preventing warts primarily involve prophylactic human papillomavirus (HPV) vaccines that target specific viral strains responsible for , with limited applicability to cutaneous warts. The primary vaccine used is 9, a nonavalent formulation that protects against nine HPV types, including 6 and 11, which cause approximately 90% of , as well as high-risk types 16 and 18 associated with and other malignancies. Another option, , is a bivalent targeting high-risk HPV types 16 and 18 for but offers no direct protection against wart-causing low-risk types like 6 and 11. These vaccines generate antibodies that prevent initial HPV infection but do not treat existing warts or infections. Clinical trials have demonstrated high efficacy for 9, with nearly 100% effectiveness in preventing caused by HPV types 6 and 11 when administered before exposure. Population-level data indicate 90-100% reductions in vaccine-targeted HPV infections and associated among vaccinated individuals. Additionally, widespread has led to indirect , reducing incidence by up to 90% in unvaccinated populations through decreased transmission. However, herd effects are limited for cutaneous warts, as current vaccines do not cover the diverse HPV types (e.g., HPV-2) responsible for common and plantar warts on non-genital skin. Emerging research as of 2025 suggests that HPV vaccines like 9 may offer off-label benefits in preventing recurrence of cutaneous warts, with complete response rates of 44-62% in some studies, possibly due to cross-reactive immune responses, though this is not yet standard prophylaxis and requires further validation. The U.S. Centers for Disease Control and Prevention (CDC) recommends routine at ages 11-12 years, with initiation possible as early as age 9, and catch-up vaccination through age 26 for those not adequately vaccinated earlier. The consists of two doses, 6-12 months apart, for individuals starting before age 15; three doses (at 0, 1-2, and 6 months) are required for those initiating at ages 15-26 or with immunocompromising conditions. For ages 27-45, vaccination is based on shared clinical decision-making due to potentially lower benefits from prior exposures. Post-vaccination surveillance data from the 2020s show an 88% decline in among U.S. adolescent girls since vaccine introduction in 2006, highlighting the impact. Despite these advances, limitations persist: HPV vaccines do not protect against all wart-causing strains, particularly those affecting cutaneous sites like HPV-2, which is prevalent in hand and foot warts. Ongoing research explores broader-spectrum , but current formulations remain focused on anogenital protection.

Treatment

Topical Medications

Topical medications for warts primarily involve keratolytic agents that chemically destroy wart tissue or immune modulators that stimulate the host's antiviral response. , available in concentrations of 17% to 40% as plasters, solutions, or soaks, acts as a keratolytic by softening and peeling away the hyperkeratotic layers of the wart, allowing penetration to infected . Daily application is recommended, often after soaking the wart in warm water to enhance efficacy, with treatment durations typically spanning 12 weeks. Pooled data from placebo-controlled trials indicate cure rates of approximately 75% for compared to 48% for , though overall efficacy ranges from 50% to 70% depending on wart location and . Over-the-counter formulations are suitable for warts on hands and feet, while higher concentrations or combined preparations may require prescription. Other topical agents target specific wart types, particularly caused by low-risk human papillomavirus strains. Imiquimod, a prescription modifier in 5% cream, enhances local production to promote viral clearance, achieving complete wart resolution in about 50% of patients after 8 to 16 weeks of thrice-weekly application. Podophyllotoxin, an antimitotic derivative available as a 0.5% or , disrupts in rapidly proliferating wart tissue and is applied twice daily for three days followed by four days off, yielding clearance rates of around 72% in . Topical 5-fluorouracil (5-FU), a cytotoxic analog in 5% cream, inhibits in HPV-infected cells and has shown high efficacy, with 95% complete eradication of plantar warts after 12 weeks when used with . These agents are prescription-only for genital applications due to potential systemic absorption risks. Common side effects across these medications include local skin irritation, , burning, and , with occasionally causing or ulceration in sensitive areas. may induce flu-like symptoms or severe in 10-20% of users, while and 5-FU can lead to blistering or if overapplied. Recent studies have explored microwave therapy as an adjunct to topical treatments like for recalcitrant plantar warts, reporting 80-83% resolution rates after 2-3 sessions combined with daily applications.

Procedural Methods

Procedural methods for treating warts involve clinician-administered techniques that physically destroy or the affected tissue, typically reserved for cases where topical treatments have failed or for multiple, large, or recalcitrant lesions. These office-based procedures aim to ablate the wart and stimulate an against the human papillomavirus (HPV), though recurrence remains possible due to viral persistence. Cryotherapy, one of the most common procedural approaches, uses at -196°C to freeze the wart tissue, causing through formation and vascular damage. It typically requires 1 to 4 sessions spaced at 2-week intervals, with each application lasting 10 to 20 seconds, and achieves a cure rate of 70-80% for common warts. Blistering and local pain are frequent side effects, but the method is generally well-tolerated and suitable for various wart types, including plantar and genital. Electrosurgery and laser ablation target deeper destruction for larger or . In , an desiccates the wart, often combined with for complete removal, yielding success rates of 65-85% but with up to 30% of scarring and recurrence. CO2 vaporizes the layer by layer, offering 80-90% efficacy in studies, particularly for recalcitrant or periungual warts, though it carries a notable scarring and is more costly. These methods are indicated for lesions unresponsive to conservative therapies due to their precision in contouring irregular surfaces. Curettage involves scraping the wart after paring the surface with a to expose the base, often followed by cautery to control bleeding and destroy residual tissue. This technique provides immediate removal but is associated with 65-85% success rates and potential for scarring in up to 30% of cases, making it appropriate for isolated, non-plantar warts. For recalcitrant warts, intralesional injection delivers the chemotherapeutic agent directly into the , inhibiting in HPV-infected cells and achieving 50-90% clearance rates after 1-3 doses. It is particularly effective for palmoplantar and periungual types, with minimal systemic absorption, though Raynaud's phenomenon can occur in digital injections. Microwave ablation, an emerging non-scarring option, applies focused to heat and denature wart , showing 80% efficacy for plantar warts in 2023 studies with fewer sessions than . This method penetrates deeper without surface damage, ideal for painful foot lesions resistant to other procedures.

Alternative Approaches

Alternative approaches to wart encompass various home-based and non-conventional methods, often employed when standard therapies are inaccessible or as adjuncts to professional care. These options typically rely on patient self-application and have varying levels of scientific support, with most backed by limited randomized controlled trials (RCTs). While some show promise in small studies, evidence is generally weaker than for established medical interventions, and users should proceed with caution to avoid complications. Emerging options as of 2025 include topical (3-6%) under , which has demonstrated clearance rates of 60-80% in recent reports, and intralesional D3 injections, with up to 80% efficacy in systematic reviews for recalcitrant warts. Duct tape occlusion therapy involves covering the wart with silver for up to six days, followed by gentle removal and stone filing, then reapplication until resolution, typically over two months. A randomized in children found this resolved 85% of warts after two months, outperforming (60% resolution), potentially due to stimulating or mild irritation. However, subsequent adult studies reported no significant advantage over occlusion with , indicating efficacy may vary by age and wart type. Apple cider vinegar soaks, applied via cotton ball to the wart and covered overnight, are a popular anecdotal remedy purported to dissolve wart tissue through acidity. Despite widespread use, there is scant supporting its effectiveness, with reports primarily limited to case anecdotes and no robust RCTs demonstrating wart clearance. This approach carries risks of chemical burns and , particularly if undiluted. Other methods include and oral zinc supplementation. Hypnotic suggestion, where patients visualize wart regression under guided relaxation, has yielded 20-50% response rates in small trials, often attributed to effects enhancing immune-mediated clearance rather than direct antiviral action. A review of studies reported average success rates of 27-55% for in wart treatment. Oral , dosed at 10 mg/kg daily for one to two months, showed clearance in up to 87% of recalcitrant warts in deficient patients in an RCT, compared to 20% with , likely by boosting . Efficacy appears higher in those with low serum zinc levels, with limited benefit otherwise. Banana peel application, rubbing the inner peel on the wart or taping it overnight, is suggested to leverage purported proteolytic enzymes for tissue breakdown, but remains unproven with no clinical trials supporting wart removal. Myths promoting home , such as using heated objects, lack evidence and pose severe risks. Overall, alternative approaches suffer from few high-quality RCTs, with outcomes influenced by spontaneous rates of 20-65% in untreated warts. Cautions are essential: acidic remedies like can cause burns, secondary s, or scarring if integrity is compromised. require professional consultation, as self-treatment may delay of potential precancerous changes or spread . Patients with immune deficiencies or persistent lesions should avoid unverified methods and seek medical advice to prevent complications.

Prognosis and Complications

Natural Resolution

Warts often resolve spontaneously without any intervention, primarily through immune-mediated mechanisms that target the human papillomavirus (HPV) infection. For common warts, approximately 65% clear within two years, reflecting the body's natural ability to mount an effective response against the virus. In contrast, tend to resolve more rapidly, with many cases clearing within one year, though they exhibit higher recurrence rates due to the mucosal environment facilitating viral persistence. The natural progression of warts typically unfolds in distinct phases. During the initial growth stage, which lasts 1 to 3 months, the lesion enlarges as HPV infects and induces . This is followed by a stability phase where the wart remains unchanged in size and appearance for several months to years. then occurs, often marked by localized , , and , spanning 2 to 6 months as the clears the infection. Several predictors influence the likelihood and speed of spontaneous clearance. Younger is associated with higher rates, as children experience clearance in about two-thirds of cases within two years, compared to slower rates in adults. Fewer lesions and peripheral locations, such as on the hands rather than pressure-bearing areas like the feet, also favor quicker . Additionally, an estimated 23% within 2 months has been observed in prospective studies of immunocompetent individuals. For small, warts, is a recommended approach, allowing time for natural resolution while monitoring for changes in size, number, or symptoms that may warrant intervention. This strategy avoids unnecessary treatments, given the high likelihood of self-resolution in many cases.

Associated Risks

Plantar warts frequently cause from mechanical pressure and during ambulation, and they may bleed if injured or subjected to repeated . Secondary bacterial infections can develop when the wart surface is disrupted, potentially leading to or formation if untreated. Treatment modalities carry their own risks, including scarring after , which may result in or hypertrophic changes. are caused by low-risk HPV types and have rare potential for , unlike infections with high-risk HPV types that can lead to precancerous . of cutaneous warts is rare but documented, particularly into verrucous carcinoma, a low-grade squamous variant typically arising on the plantar surface or in chronic lesions. Recurrence is a common issue, affecting 20-50% of treated warts overall due to persistent subclinical HPV or reinoculation. Rates are substantially higher in immunocompromised individuals, often exceeding 50%, as impaired hinders viral clearance. Beyond physical complications, warts can impose psychological burdens, including embarrassment and reduced , with genital lesions often exacerbating distress due to their location and .

History

Etymology and Early Descriptions

The English word "wart" originates from the Old English wearte, which derives from the Proto-Germanic *wartōn, denoting a small, hard, fleshy excrescence on the skin. This term is etymologically related to the Latin verruca, initially meaning a steep place or eminence, later applied in and to describe wart-like protuberances on or the . The Greek equivalents included myrmēkía (anthill-like, for clustered or deep warts) and kondýloma (knuckle or knob-shaped). Early medical observations of warts date to ancient Greece and Rome. In the Hippocratic Corpus (c. 400 BCE), Hippocrates described pedunculated warts occurring in children, classifying skin excrescences as arising from imbalances in the four bodily humors—blood, phlegm, yellow bile, and black bile—rather than external agents. The Roman author Aulus Cornelius Celsus, in De Medicina (c. 1st century CE), provided the first detailed differentiation, identifying three varieties: acrochórdes (elongated skin tags), thýmion (possibly genital warts resembling thyme buds), and myrmēkía (painful, deep-rooted plantar warts). Biblical texts may also allude to warts; Leviticus 22:22 prohibits sacrificial animals with yabbēlet (translated as "wart" or "excrescence" in some renderings), suggesting early recognition of such skin blemishes as impurities. In the pre-microscope era, particularly during , warts were frequently attributed to humoral imbalances or influences rather than microbial causes. Folk beliefs linked them to curses or , with witches purportedly charming warts away using special stones like crystals. A persistent held that handling toads could transmit warts, equal in number to the animal's spots, reflecting associations between amphibians and malevolent forces in lore. These views persisted until the , when viral etiologies began to emerge.

Evolution of Treatments

In ancient times, warts were documented as a distinct in medical texts dating back to around 460–370 BCE, with early treatments relying on herbal caustics and mechanical removal. Practitioners applied plant-based substances with irritant properties, such as the latex from fig trees (Ficus carica), which contains proteolytic enzymes capable of breaking down wart tissue, a method referenced in classical Greco-Roman medicine. Surgical excision, involving the cutting out of warts with simple tools under rudimentary conditions, was also employed for larger lesions, though it carried risks of and scarring. By the , advancements in chemistry led to the isolation and application of , derived from willow bark (Salix spp.), as a keratolytic agent for skin conditions including warts from the late 19th century onward. This compound, synthesized more efficiently by in 1860 and refined for topical use, worked by softening and peeling away hyperkeratotic skin layers, marking a shift toward more targeted chemical over crude herbals. In the early , radiation-based approaches emerged, with introduced around the 1910s–1920s for plantar and common warts, leveraging to destroy abnormal tissue; however, by the mid-20th century, it was largely abandoned due to documented risks of inducing skin cancers, including , in treated patients. The 20th century brought further innovations, including the establishment of warts' viral etiology, which propelled targeted treatments. In 1907, Giuseppe Ciuffo demonstrated the infectious nature of human papillomavirus (HPV) by successfully inoculating wart extracts into , confirming a filterable viral agent; this was expanded in the 1970s through molecular virology, linking specific HPV types to wart formation. gained prominence in the 1930s, with French physicians Lortat-Jacob and Solente pioneering the use of solid snow for freezing warts, followed by applications that induced of infected tissue with minimal equipment. The 1980s and saw the rise of immunomodulatory therapies, exemplified by , an modifier approved in the late (with early trials in the ) that stimulates local production to enhance antiviral defenses against HPV. The turn of the emphasized prevention and less invasive options, highlighted by the 2006 approval of the vaccine, which targets HPV types 6 and 11 responsible for approximately 90% of , reducing incidence through prophylactic immunization. This era also reflected a broader evolution from purely destructive methods (e.g., excision, , radiation) to those promoting immune clearance, such as topical immunomodulators. Recent developments include microwave therapy trials in 2023, which deliver controlled thermal energy to ablate warts while stimulating immunity, achieving clearance rates of 68–83% in pediatric and plantar cases after 2–3 sessions, offering a promising non-chemical alternative for recalcitrant lesions.

References

  1. [1]
    Wart - StatPearls - NCBI Bookshelf - NIH
    Aug 14, 2023 · Warts are benign lesions that occur in the mucosa and skin. Warts are caused by the human papillomavirus (HPV), with over 100 types of HPV identified.
  2. [2]
    Common warts - Symptoms and causes - Mayo Clinic
    May 16, 2024 · Common warts are small, grainy skin growths that occur most often on the fingers or hands. They're rough to the touch and often have tiny black dots.
  3. [3]
    Plantar warts - Symptoms and causes - Mayo Clinic
    Feb 7, 2024 · Learn about the causes, treatment and prevention of these hard, sometimes painful growths that appear on the heel or ball of the foot.
  4. [4]
    Common warts - Diagnosis and treatment - Mayo Clinic
    May 16, 2024 · Treatment · Prescription-strength peeling medicine. Wart medicines with salicylic acid work by removing layers of a wart a little bit at a time.
  5. [5]
    HPV infection - Symptoms & causes - Mayo Clinic
    Some types of HPV infection cause skin growths called warts and some types of HPV infection can cause cancer. Most HPV infections don't lead to cancer.
  6. [6]
    Overview: Warts - InformedHealth.org - NCBI Bookshelf
    Jan 11, 2023 · Warts are non-cancerous (benign) skin growths that develop on different parts of the body and come in various forms. They are caused by viruses.
  7. [7]
    An Improved Protocol for Comprehensive Etiological ... - NIH
    Oct 15, 2022 · Among the five most frequent causative HPV types, HPV2 had the highest proportion (17/19; 89.5%) of common wart samples in which it was ...
  8. [8]
    Human papillomavirus (HPV) infection - NCBI - NIH
    (i) Typical common or mosaic warts, i.e. rough keratotic papules or nodules, on the hands, knuckles or periungual areas contain HPV-2, -4, -7, -26, -27, -28 or ...
  9. [9]
    Entodermoscopy Update: A Contemporary Review on Dermoscopy ...
    Second point of difference between a palmo-plantar wart and corn/callosity is that the skin lines or dermatoglyphics get typically interrupted in warts, but ...
  10. [10]
    Corns - StatPearls - NCBI Bookshelf - NIH
    Jul 24, 2023 · ... differentiate corns and calluses from other diseases like a plantar wart. ... In corns, the plantar skin lines may be observed within the lesions, ...
  11. [11]
    Warts - Dermatologic Disorders - Merck Manual Professional Edition
    These warts are caused by HPV types 1, 2, and 4. They occur on the palms and soles. Palmar and plantar warts are flattened by pressure and surrounded by ...
  12. [12]
    Plantar Warts: Symptoms, Causes, Treatment & Removal
    Apr 12, 2023 · Plantar warts are rough bumps caused by HPV. They may be uncomfortable or hurt. They commonly appear on the soles of your feet.
  13. [13]
    Warts, verrucas, human papillomavirus infection - DermNet
    Plantar warts (verruca plantaris) include tender inwardly growing myrmecia on the sole caused by HPV 1, and clusters of superficial less painful mosaic warts ...Missing: sources | Show results with:sources
  14. [14]
    Plantar warts: Symptoms, causes, and treatment - MedicalNewsToday
    Jul 22, 2019 · Plantar warts are small, noncancerous growths on the soles that occur due to a human papillomavirus (HPV) strain.
  15. [15]
    Plantar warts: Options for treating this common foot condition
    May 19, 2025 · Plantar warts develop when the HPV virus enters the skin through tiny cuts or breaks. This virus thrives in warm, moist environments, making ...Missing: distinction reliable
  16. [16]
    Plantar Warts and Palmar Warts: Treatments and Causes - WebMD
    Jun 26, 2024 · Plantar warts and palmar warts are noncancerous skin growths, caused by a viral infection in the top layer of the skin.
  17. [17]
    Flat Wart (HPV): Causes, Symptoms, and Treatment - Skinsight
    Jun 20, 2024 · In lighter skin colors, flat warts may be pink, skin-colored, or yellowish-brown. In darker skin colors, flat warts may be whitish, pink, purple ...Missing: Koebner phenomenon
  18. [18]
    Wart Variants and Other HPV-Related Lesions - MSD Manuals
    Wart Variants and Other HPV-Related Lesions ; Flat warts (plane warts). Smooth, flat-topped, yellow-brown, pink, or skin-colored papules ; Keratoacanthoma.
  19. [19]
    Flat Warts and Syringomas - Contemporary Pediatrics
    Flat warts can be white, pink-brown, or skin-colored. The number of lesions ranges from several to hundreds. The papules may be partially grouped, not grouped, ...Missing: groups | Show results with:groups
  20. [20]
    Skin Lesions Caused by HPV—A Comprehensive Review - PMC - NIH
    Flat warts are smooth, skin-colored lesions that usually appear on the face, neck, hands, and wrists and are caused by HPV types 3 and 10 [7]. Epidermodysplasia ...
  21. [21]
    Human papillomavirus molecular biology and disease association
    Flat warts are slightly raised lesions of skin color or pigmented, with flat, smooth or, slightly rough surface. The face and back of hands are the most common ...
  22. [22]
    Warts - Primary Care Dermatology Society
    May 28, 2022 · Shaving spreads warts over the beard area; New warts may develop along the sites of trauma, this is known as the Koebner phenomenon. The ...Patient Information Leaflet · Clinical Findings · Management<|control11|><|separator|>
  23. [23]
    Filiform warts: What they look like, treatment, and causes
    Mar 28, 2018 · Filiform warts are caused by HPV strains 1, 2, 4, 27, and 29. However, exposure to these strains does not guarantee that warts will develop. ...Identification · Treatment · Home removal · Causes
  24. [24]
    Filiform Warts: Causes, Removal, and Home Remedies - Healthline
    Nov 1, 2020 · Filiform warts are caused by human papillomavirus (HPV). If you have HPV, you can spread the warts to other people via skin contact, especially if the skin is ...Pictures · Causes · Removal
  25. [25]
    Human Papillomavirus and Warts (also known as “HPV infection ...
    Filiform warts, variants of the common wart, can manifest on the lips. They are elongated, pointed, and delicate lesions that may reach 1 cm in length.<|control11|><|separator|>
  26. [26]
    Warts: How To Identify, Causes, Types, Treatment & Prevention
    around your mouth, eyes and nose. HPV types 1, 2, 4, 27 and ...
  27. [27]
    Genital warts - Symptoms and causes - Mayo Clinic
    Dec 19, 2023 · Genital warts affect the moist tissues of the genital area. They can look like small, skin-colored bumps. The bumps may resemble cauliflower.Female genital warts · Male genital warts · Diagnosis and treatment
  28. [28]
    Anogenital Warts - Human Papillomavirus (HPV) Infection - CDC
    Jul 22, 2021 · They are usually flat, papular, or pedunculated growths on the genital mucosa. Anogenital warts occur commonly at certain anatomic sites, ...
  29. [29]
    Human papillomavirus and cancer - World Health Organization (WHO)
    Mar 5, 2024 · Some HPV infections cause small rough lumps (genital warts) that can appear on the vagina, penis or anus and rarely the throat.Overview · Scope Of The Problem · TreatmentMissing: clinical | Show results with:clinical
  30. [30]
    Natural Course of Cutaneous Warts Among Primary Schoolchildren
    Warts are very common in the general population, especially among children. The prevalence of warts among primary schoolchildren is reported to be 22% to 33%, ...
  31. [31]
    HPV Infection in Children and Adolescents—A Comprehensive ...
    Apr 2, 2025 · HPV infection in children can present as common skin warts, anogenital warts, or, in rare cases, Juvenile Recurrent Respiratory Papillomatosis ( ...
  32. [32]
    Increasing incidence of anogenital warts with an urban–rural divide ...
    Mar 3, 2016 · Urban effects on the incidence of anogenital warts​​ AGW incidence was higher in urban areas for both females and males (Fig. 3). The trend lines ...
  33. [33]
    [PDF] Demographical Study of Cutaneous Warts Caused by Human ...
    The study found that wart prevalence was higher among patients who lived in urban regions compared to those who lived in rural regions. RECOMMENDATIONS. PCR- ...
  34. [34]
    A cross-sectional study of 3120 patients at Razi hospital - NIH
    Some diseases demonstrated significant seasonality with a peak during the winter, including acne, eczema, wart, seborrheic dermatitis, nevus, vitiligo, lentigo ...
  35. [35]
    Epidemiological Characteristics of Patients with Plantar Warts
    Cutaneous warts may exhibit seasonal variations. Among them, the incidence of plantar warts is reported to rise during the winter months. In Korea, to ...
  36. [36]
    DELETE - Condyloma Acuminatum (Genital Warts)
    Mar 21, 2024 · Frequency. United States. Annual incidence of condyloma acuminatum is 1%. It is considered the most common sexually transmitted disease (STD).Background · Pathophysiology · Epidemiology
  37. [37]
    The frequency of HPV infection worldwide - HPV World
    Findings showed that on average, 12% of women worldwide had a detectable cervical HPV infection (5). The estimate varied by geography and age (Figure 1 and ...
  38. [38]
    HPV vaccination is highly effective at preventing genital warts
    Studies have shown that there was a 76%, 52% and 90% reduction in quadrivalent HPV genotypes in the anus, genital and oral cavity, respectively, among young MSM ...
  39. [39]
    Population-Level Impact of Human Papillomavirus Vaccination on ...
    HPV vaccination programs have significantly reduced incidence of genital warts in Sweden, especially among women aged 15–34 years. Incidence among men has.
  40. [40]
    Human Papillomavirus Epidemiology and Prevention: Is There Still a ...
    Cutaneous warts (CWs), also known as verrucae, generally affect children and young adults and peak between 10 and 14 years of age. CWs are mainly caused by the ...Human Papillomavirus... · 4. Clinical Manifestation · 5. PreventionMissing: demographics teens differences
  41. [41]
    Nongenital Warts: Background, Pathophysiology, Etiology
    Aug 19, 2025 · In school-aged children, the prevalence is 10-20%. An increased frequency also is seen among immunosuppressed patients and meat handlers.
  42. [42]
    Systematic review of the incidence and prevalence of genital warts
    Jan 25, 2013 · New AGW incidence rates among males ranged from 103 to 168 per 100,000, with a median of 137 per 100,000 and among females from 76 to 191 per ...
  43. [43]
    Epidemiology and associated factors of genital warts among ...
    2.1. Study design. This cross-sectional study was performed on 679 individual with genital warts, consisted of 498 (73.3 %) men and 181 (26.7 %) females who ...
  44. [44]
    Human Papillomavirus Infection in Solid Organ Transplant Recipients
    The prevalence of warts in transplant patients is proportional to the duration of immunosuppressive therapy, increasing to 50–92% in patients who are more than ...
  45. [45]
    Human Papillomavirus Disease: Adult and Adolescent OIs | NIH
    Jul 9, 2024 · People with HIV may have larger or more numerous warts, may not respond as well to therapy for genital warts as individuals who are ...
  46. [46]
    Wart Removal | Skin and Cancer Institute
    Several risk factors increase susceptibility to warts. These include ... Nail biting and cuticle picking; Shaving over existing warts. We observe that ...Missing: trauma | Show results with:trauma
  47. [47]
    So-Called Butcher's Warts Appeared on the Hands of a Meat Handler
    Nov 9, 2020 · We present a case of so-called butcher's warts in a meat handler with atopic dermatitis. PCR with direct sequence analysis confirmed the presence of HPV 7 in ...
  48. [48]
    Epidermodysplasia Verruciformis - Medscape Reference
    Aug 25, 2025 · Epidermodysplasia verruciformis (EV) is a rare, inherited disorder that predisposes patients to widespread human papillomavirus (HPV) infection and cutaneous ...Background · Pathophysiology · Etiology · Epidemiology
  49. [49]
    Anogenital Warts in Geriatrics: Immunosenescence and New Sexual ...
    Sep 9, 2024 · The aging process leads to a decline in immune function among geriatric individuals, which causes susceptibility to infections, including STIs.
  50. [50]
    Flat Warts: Causes & Treatment - Cleveland Clinic
    Oct 25, 2022 · Other risk factors include: Touching an object that has come into contact with HPV. Having open cuts and scrapes. Exercising poor hygiene.
  51. [51]
    Chapter 11: Human Papillomavirus | Pink Book - CDC
    Apr 23, 2024 · More than 90% of cases of anogenital warts are caused by low-risk HPV types 6 or 11.
  52. [52]
    Human Papillomavirus - StatPearls - NCBI Bookshelf
    The HPV subtypes which cause cutaneous verrucae are spread by contact between skin with microscopic or macroscopic epidermal damage and a fomite-harboring HPV. ...
  53. [53]
    Cutaneous warts (common, plantar, and flat warts) - UpToDate
    Jan 2, 2025 · HPV type 1 commonly infects the soles of the feet and produces plantar warts, while HPV types 6 and 11 infect the anogenital area and cause ...
  54. [54]
    HPV (Human Papillomavirus): Causes, Symptoms & Treatment
    All warts are caused by HPV, but not all strains or types of HPV cause warts. The type of HPV that can progress to cancer doesn't cause warts. How do you spread ...Missing: Papillomaviridae family
  55. [55]
    The Biology of Papillomavirus Latency - PMC - PubMed Central
    Anecdotal tales suggest that latent human papillomavirus infections can sometimes undergo reactivation leading to disease recrudescence. The high recurrence ...
  56. [56]
    The human Papillomavirus twilight zone – Latency, immune control ...
    Such results suggest that papillomaviruses may persist in a latent state after disease clearance, with sporadic recurrence.
  57. [57]
    Persistent Human Papillomavirus Infection - PMC - PubMed Central
    Therefore, HPV latency could increase the likelihood of persistent infection in the human population.
  58. [58]
    Warts transmitted in families and schools: a prospective cohort
    This study examines the association between the degree of HPV exposure and incidence of warts in primary schoolchildren to support evidence-based ...Missing: outbreaks | Show results with:outbreaks
  59. [59]
    Warts Are Transmitted in Homes and Schools - NEJM Journal Watch
    May 15, 2013 · Use of public pools, showers, and sports facilities did not significantly increase risk for wart acquisition.
  60. [60]
    Communal showers and the risk of plantar warts - PubMed
    The present study suggests that public shower users are at greater risk for plantar warts than are locker room users who do not use communal showers.Missing: transmission | Show results with:transmission
  61. [61]
    Genital Warts: A Comprehensive Review - PMC - NIH
    External genital warts, also known as condylomata acuminata, are extremely common ... dome-shaped, cauliflower-shaped, or pedunculated.13 EGW can manifest ...
  62. [62]
    Sex- and type-specific genital human papillomavirus transmission ...
    The estimated median transmission rate from an HPV-positive to a negative partner was 4.2 (95%PI 3.1–5.3) per 100 person–months. The transmission rate from men ...
  63. [63]
    Transmission of Human Papillomavirus in Heterosexual Couples - NIH
    Rate of transmission from penis to cervix was lower than that from cervix to penis; 13 different genotypes were sexually transmitted. Keywords: Human ...
  64. [64]
    Epidemiology and transmission dynamics of genital HPV infection
    A study of the transmissibility of genital warts, conducted before HPV was identified as the causal agent, observed that 60% of sexual partners of patients ...
  65. [65]
    Non-sexual HPV transmission and role of vaccination for a ... - NIH
    Oct 13, 2020 · The route of HPV transmission is primarily through skin-to-skin or skin-to-mucosa contact. Sexual transmission is the most documented.
  66. [66]
    A risk for non-sexual transmission of human papillomavirus?
    Sep 9, 2014 · Here, we educate that HPVs are very stable viruses, able to survive on fomites and surfaces for days. This is based on multiple studies both in ...
  67. [67]
    Dynamics of papillomavirus in vivo disease formation ...
    A mouse tail infection model showed a clear dose-response for disease formation, that papillomaviruses remain stable and infective on fomite surfaces for at ...
  68. [68]
    Human Papillomavirus (HPV) - Medscape Reference
    Aug 22, 2024 · ... are highly species-specific and do not infect other species, even under laboratory conditions. Humans are the only known reservoir for HPV.
  69. [69]
    Current understanding of the mechanism of HPV infection - PMC - NIH
    L2 proteolysis exposes a previously occluded surface of L1 that binds an as yet undetermined cell surface receptor on keratinocytes that have migrated over the ...
  70. [70]
    Pathogenesis of Human Papillomaviruses in Differentiating Epithelia
    The life cycle of HPV is linked to the differentiation program of the infected host cell, the keratinocyte, with production of mature virion particles ...
  71. [71]
    Mechanisms by which HPV Induces a Replication Competent ...
    Sep 19, 2017 · HPV infects the basal layer of the stratified epithelium through a microwound. Upon entry into the cell, the virus transiently amplifies to 50– ...
  72. [72]
    The Invisible Enemy – How Human Papillomaviruses Avoid ...
    The most important HPV immune evasion mechanism is to become invisible to the host immune system. This includes the absent triggering of any danger signals, as ...
  73. [73]
    Evasion of Host Immune Defenses by Human Papillomavirus - PMC
    Here, we discuss cellular pathways dysregulated by HPV that allow the virus to evade various host immune defenses.3. Immune Evasion By... · 4. Immune Evasion By... · 5. Immune Evasion By Altered...
  74. [74]
    The Immune Response to Papillomavirus During Infection ... - NIH
    Persistent infections with HPV occur primarily because the virus can subvert the immune response, allowing its continued presence in an immune competent host.Regression Of Hpv Lesions... · Nk And Nkt Cells Contribute... · Antigen Presentation Is The...<|control11|><|separator|>
  75. [75]
    Immune therapy for human papillomaviruses-related cancers - PMC
    First, HPV can infect cells through damaged skin tissue. When the damage reaches the basal layer of the epidermis, the virions can infect dividing keratinocytes ...
  76. [76]
    Spontaneous regression of plane warts after inflammation - PubMed
    In all the patients, there was a sudden and systemic onset of inflammation in every flat wart. Within two to six weeks, all the warts completely involuted.
  77. [77]
    The Effectiveness of Cutaneous Wart Resolution with Current ... - NIH
    Non-venereal warts are a frequent dermatological presentation with potential spontaneous regression in immunocompetent adults and children within 2 years.
  78. [78]
    Immunosuppression Facilitates the Reactivation of Latent ... - NIH
    Our studies provide direct evidence that immunosuppression can trigger the reactivation of latent papillomavirus genomes, as previously proposed in humans.
  79. [79]
    Human papillomavirus in the setting of immunodeficiency
    Both CD4+ and CD8+ T cell responses were associated with HPV-E6-related lesion regression, while E7 regression has been attributed solely to a CD4+ T cell ...<|control11|><|separator|>
  80. [80]
    Nongenital Warts Clinical Presentation: History, Physical Examination
    Aug 19, 2025 · They range from smaller than 1 mm to larger than 1 cm. They ... Filiform warts are long slender growths that are usually seen on the ...
  81. [81]
    Dermoscopy Features of Cutaneous Warts - PMC - PubMed Central
    Dec 16, 2021 · Cutaneous warts are benign epithelial skin lesions, caused by human papilloma virus (HPV). These warts can affect any part of the body, ...Common Warts · Figure 1 · Figure 2<|control11|><|separator|>
  82. [82]
    Update on Dermoscopy and Infectious Skin Diseases - PMC
    Dec 31, 2019 · Common warts usually show at dermoscopy as grouped papillae, with dotted or loop vessels, and/or hemorrhagic points and lines often surrounded ...
  83. [83]
    Human Papillomavirus (HPV) Workup - Medscape Reference
    Aug 22, 2024 · Acetic Acid Test. The acetic acid test is useful in diagnosing genital warts, enhancing suspicion for lesions lacking classic features. This ...
  84. [84]
    HPV infection - Diagnosis & treatment - Mayo Clinic
    Another prescription applied to the skin, podofilox works by killing genital wart tissue. Podofilox may cause burning and itching where it's applied.Symptoms & causes · Doctors and departments · Pap smear<|control11|><|separator|>
  85. [85]
    Warts (verrucae) - Pathology Outlines
    Jan 3, 2025 · Warts are a common viral infection of skin and mucosal epithelial cells; are caused by human papilloma virus (HPV)Missing: confirmatory tests PCR DNA acetic whitening ultrasound
  86. [86]
    Biopsy of Genital Warts (Human Papillomavirus) - Kaiser Permanente
    A microscopic exam on the biopsied tissue can help your doctor find out whether human papillomavirus (HPV), Opens dialog is present.
  87. [87]
    Laboratory diagnosis of human papillomavirus virus infection ... - NIH
    The important methods to diagnose HPV infection are: Colposcopy and acetic acid test. Biopsy. DNA test (PCR, Southern Blot Hybridization, In Situ Hybridization).
  88. [88]
    Sonography of plantar warts: role in diagnosis and treatment - PubMed
    Sonography may be considered as reliable support for plantar wart diagnosis and may have a role in the evaluation of plantar wart treatment modalities.
  89. [89]
    Plantar wart | Radiology Reference Article - Radiopaedia.org
    Mar 20, 2022 · Ultrasound. The diagnosis is primarily clinical but may be seen as a hypoechoic lesion lying subdermally along the plantar surface of the feet.
  90. [90]
    8 dermatologists' tips for preventing warts
    Having damp, soft skin may increase the risk of getting HPV infection, which could lead to a wart. If you develop a wart. The virus that causes warts is found ...
  91. [91]
    Periungual warts: Pictures, treatment, and prevention
    Nov 10, 2023 · Avoid biting or picking at the fingernails or cuticles. Wear protective gloves when washing the dishes. Do not share towels, nail polish, or ...What do they look like? · Causes and risk factors · Complications · Treatment
  92. [92]
    Periungual Warts: Identification, Treatment, and More - Healthline
    Nov 5, 2020 · How can you prevent spreading periungual warts? · Wash your hands often. · Don't bite your fingernails or pick your cuticles. · Wear protective ...
  93. [93]
    Popular disinfectants do not kill HPV | Penn State University
    Feb 12, 2014 · "Chemical disinfectants used in the hospitals and other healthcare settings have absolutely no effect on killing human papillomavirus," Meyers ...
  94. [94]
    Human Papillomavirus (HPV) Vaccines - National Cancer Institute
    May 25, 2021 · The trials that led to approval of Gardasil 9 found it to be nearly 100% effective in preventing cervical, vulvar, and vaginal infections and ...
  95. [95]
    HPV Vaccination - CDC
    Aug 20, 2024 · HPV vaccine has the potential to prevent more than 90% of cancers caused by HPV. Fewer teens and young adults are getting genital warts. HPV ...
  96. [96]
    Impact and Effectiveness of the Quadrivalent Human Papillomavirus ...
    Maximal reductions of approximately 90% for HPV 6/11/16/18 infection, approximately 90% for genital warts, approximately 45% for low-grade cytological cervical ...Results · Reductions In Hpv 6/11/16/18... · Cervical Cytological And...
  97. [97]
    Evaluation of vaccination herd immunity effects for anogenital warts ...
    Aug 14, 2017 · Clinical trials have shown HPV vaccine efficacy of 90–100% for ... Strongly decreased risk of genital warts after vaccination against ...Data Source · Statistical Analysis · Author Information<|separator|>
  98. [98]
    Nonavalent Human Papillomavirus Vaccination as a Treatment for ...
    Most of the HPV types in common skin warts are not targeted by the vaccine. However, its mechanism of action is still unclear. There is a significant homology ...
  99. [99]
    HPV Vaccination Recommendations - CDC
    Three doses of HPV vaccine are recommended for teens and young adults who start the series at ages 15 through 26 years, and for immunocompromised persons.ACIP Recommendations · HPV Vaccine Safety and... · Tools and ResourcesMissing: warts | Show results with:warts
  100. [100]
    A broadly protective vaccine against cutaneous human ... - Nature
    Oct 10, 2022 · Current HPV prophylactic vaccines are not effective against cutaneous HPV types (cHPV). By applying a modular polytope-based approach, in this ...
  101. [101]
    A Comprehensive Review of Treatment Approaches for Cutaneous ...
    Oct 25, 2023 · Salicylic acid 17% is most frequently used; however, there isn't enough information to say that one preparation or concentration is better than ...
  102. [102]
    An Armamentarium of Wart Treatments - PMC - PubMed Central
    Verruca vulgaris (common warts) are hyperkeratotic, exophytic and dome-shaped papules or nodules especially located on fingers, hands, knees, elbows or any ...
  103. [103]
    Salicylic acid (topical route) - Side effects & dosage - Mayo Clinic
    Jun 30, 2025 · Inflammation, irritation, or infection of the skin—Use of this medicine may cause severe irritation if applied to inflamed, irritated, or ...
  104. [104]
    Imiquimod for the treatment of genital warts - PubMed Central - NIH
    The results of the pooled analysis tell us that about 50% of patients will have their warts cleared with 5% imiquimod, and that 40% will have warts cleared and ...
  105. [105]
    Efficacy and safety of imiquimod versus podophyllotoxin ... - PubMed
    The rates of clearance of baseline warts among treatment groups were 72% (95% confidence interval [CI], 52%-86%) in the podophyllotoxin group and 75% (95% CI, ...
  106. [106]
    Topical 5% 5-fluorouracil cream in the treatment of plantar warts
    Nineteen out of 20 patients (95%) randomized to 5% 5-FU with tape occlusion had complete eradication of all plantar warts within 12 weeks of treatment. The ...
  107. [107]
    Podofilox (topical route) - Side effects & dosage - Mayo Clinic
    Feb 1, 2025 · More common · Bad odor (solution only) · bleeding of treated skin · blistering, crusting, or scabbing of treated skin · bloody urine (solution only) ...
  108. [108]
    Imiquimod (topical route) - Side effects & dosage - Mayo Clinic
    Jan 31, 2025 · More common · Burning or stinging of the skin (mild) · flaking of the skin · mild headache · pain, soreness, or tenderness of the skin (mild) · rash ...
  109. [109]
    Microwave therapy for the treatment of plantar warts
    Jun 15, 2023 · This retrospective study has shown that plantar warts may be resolved with two to three sessions of microwave therapy, which may be more successful in younger ...Missing: adjunct | Show results with:adjunct
  110. [110]
    Nongenital Warts Treatment & Management - Medscape Reference
    Aug 19, 2025 · Although electrodesiccation with curettage may be more effective than cryosurgery, it is painful and more likely to cause scarring; in addition, ...
  111. [111]
    The Efficacy of Duct Tape vs Cryotherapy in the Treatment of ...
    This method involves freezing a wart with liquid nitrogen for 10 to 20 seconds every 2 to 3 weeks. Precisely how cryotherapy destroys warts is not well ...
  112. [112]
    Comparison of the Efficacy and Safety of Two Cryotherapy Protocols ...
    Jul 13, 2020 · Cryotherapy (freezing by liquid nitrogen) is an effective and widely used method for treatment of common warts. Patients often need multiple ...
  113. [113]
    Electrodesiccation and Curettage for Removal of Nongenital Warts
    Apr 15, 2012 · Although success rates of 65 to 85 percent have been reported, scarring and recurrence occur in up to 30 percent of patients.
  114. [114]
    Cryotherapy versus CO2 laser in the treatment of plantar warts - NIH
    Jul 31, 2018 · In this study, we compared CO2 laser and cryotherapy in order to determine their efficacy. Our remission rate in the CO2 laser group was 89%.
  115. [115]
    CO2 laser vaporization as primary therapy for human papillomavirus ...
    Jan 11, 2002 · Laser approach resulted in a satisfactory warts clearance (87.5%) and low recurrence rate (12.5%) after twelve months, as well as appearing to ...
  116. [116]
    Destructive therapies for cutaneous warts: A review of the evidence
    Cryotherapy with liquid nitrogen causes direct cell damage and subsequent inflammatory response (Figure 1B). A meta-analysis of three RCTs surprisingly found no ...
  117. [117]
    Efficacy of Intralesional Bleomycin in Palmo-plantar and Periungual ...
    The intralesional injection of bleomycin is highly effective, safe, and non-toxic in periungual and palmo-plantar warts.
  118. [118]
    A Prospective Comparative Study of Efficacy of Intralesional
    Various literature suggests on the use of intralesional bleomycin for the treatment of warts, with cure rates ranging from 14% to 99%.
  119. [119]
    The treatment of plantar warts using microwave-A review of 85 ...
    Jun 20, 2023 · Conclusions: Microwave treatment of verrucae plantaris appears to be a safe and effective procedure.
  120. [120]
    The treatment of plantar warts using microwave—A review of 85 ...
    Jun 20, 2023 · There were 31 patients who received three sessions of microwave therapy with a clearance rate of 71.0% (22/31) as per intention-to-treat (27 ...
  121. [121]
    The efficacy of duct tape vs cryotherapy in the treatment of verruca ...
    Conclusion: Duct tape occlusion therapy was significantly more effective than cryotherapy for treatment of the common wart. Publication types. Clinical Trial ...
  122. [122]
    Duct tape for the treatment of common warts in adults - PubMed
    We found no statistically significant difference between duct tape and moleskin for the treatment of warts in an adult population.
  123. [123]
    Can You Remove Warts with Apple Cider Vinegar? - Healthline
    Unfortunately, there is little scientific proof that apple cider vinegar is reliably effective for treating warts.The claims · Methods · Research
  124. [124]
    Apple cider vinegar to remove warts: Effectiveness and side effects
    Feb 27, 2018 · Apple cider vinegar's effectiveness for treating warts is not known, and there are reports of risks and complications with this home remedy.Effectiveness · Step-by-step guide · Side effects · Other treatmentsMissing: evidence | Show results with:evidence
  125. [125]
    Hypnosis, placebo, and suggestion in the treatment of warts - PubMed
    In Experiment 2, hypnotic and nonhypnotic subjects given the same suggestions were equally likely to exhibit wart regression and more likely to show this effect ...
  126. [126]
    The Role of Hypnosis in Dermatology: More than Mere Suggestion
    Mar 11, 2020 · Published studies show, on average, between 27-55 percent success rates in treating warts using hypnosis. One such study showed that 53 percent ...Missing: removal | Show results with:removal
  127. [127]
    Oral zinc sulphate in the treatment of recalcitrant viral warts - PubMed
    We conclude that zinc sulphate at a dose of 10 mg kg(-1) daily seems to be a highly efficacious therapeutic option for recalcitrant viral warts.
  128. [128]
    Clinical use of zinc in viral warts: a systematic review of the clinical ...
    Zinc has shown promise in the treatment of patients with viral warts in several clinical trials, but there is no consensus on its effectiveness.
  129. [129]
    Can people use banana peels to treat warts? - MedicalNewsToday
    Apr 29, 2022 · There is currently no evidence that banana peels can remove warts, but they are safe to use and have several benefits. Learn more here.Missing: proteolytic enzymes
  130. [130]
    4 home remedies for warts: Do they work, and are they safe?
    Some home remedies people can apply to a wart include duct tape, homemade aspirin paste, and ACV. However, there is little evidence that these treatments work.How to treat tongue warts and... · Flat warts · Plantar warts · Types of warts
  131. [131]
    Management of External Genital Warts - AAFP
    Sep 1, 2014 · The preparation causes wart regression and necrosis by stopping mitosis. The solution is applied to warts up to once weekly for three to six ...
  132. [132]
    Epidemiology and Clinical Profile of Cutaneous Warts in Chinese ...
    Oct 18, 2018 · The prevalence of warts is 1.4% in college students. The majority of patients have warts <1 cm and approximately 2/3 patients has one wart.Missing: geographic climates<|separator|>
  133. [133]
    Natural Course of Cutaneous Warts Among Primary Schoolchildren
    When newly developed warts were excluded, the resolu- tion rate of baseline warts was even higher: 90 per 100 person- years (95% CI, 79-100). Rates were similar ...
  134. [134]
    Cutaneous Warts: An Evidence-Based Approach to Therapy - AAFP
    Aug 15, 2005 · A study2 examining the natural progression of warts indicated that warts will spontaneously clear after two years without treatment in 40 ...
  135. [135]
    Consideration of underlying immunodeficiency in refractory or ... - NIH
    Feb 9, 2022 · Patients with extensive, recalcitrant, or treatment‐refractory warts may have an underlying immune system impairment at the root of HPV susceptibility.
  136. [136]
    Wart - Etymology, Origin & Meaning
    Originating from Old English "weart" and Proto-Germanic *warton-, "wart" means a small, circumscribed fleshy excrescence, related to Latin verruca "swelling ...
  137. [137]
    Verruca - Etymology, Origin & Meaning
    Originating c. 1400 from Latin verruca meaning "wart, hillock," the word denotes a wart or wart-like growth; its uncertain origin may relate to PIE roots ...
  138. [138]
    The History and Folklore of Warts: A Review - Sage Journals
    Originally meaning a steep place or height, Sennertus applied the term to warts because 'They appear on the surface of the skin like the eminences of little ...<|control11|><|separator|>
  139. [139]
    History of dermatology: the study of skin diseases over the centuries
    Hippocrates proposed the first classification of skin diseases, dividing ... warts, lupus erythematosus, and basal cell carcinoma. Despite easy access ...Missing: tubers | Show results with:tubers
  140. [140]
    Vayikra - Leviticus - Chapter 22 (Parshah Emor) - Chabad.org
    It shall not have any defect in it. 22[An animal that has] blindness, or [a] broken [bone], or [a] split [eyelid or lip], or [one that has] warts, or dry ...Missing: shikkin | Show results with:shikkin
  141. [141]
    Wicked Cures for the Warty—A Historical Perspective - JAMA Network
    Physical agents applied to warts have been used in the past and present. Common plants used were dandelion (juice), numerous spe- cies of Euphorbia, and ...
  142. [142]
    Wart Removal Across the Ages - Pulse Light Clinic
    Aug 13, 2024 · People often believed that warts were caused by evil spirits or witches, leading to the development of bizarre remedies. One popular medieval ...
  143. [143]
    The Story of Aspirin - National Library of Medicine
    In 1860, Hermann Kolbe (1818–1884), a German scientist, created a method to synthesize salicylic acid, the building block of aspirin, from smaller molecules, ...
  144. [144]
    View of X-ray treatment of plantar warts and the development of skin ...
    ... X-ray treatment was used as a standard treatment for plantar warts from the 1930s to the late 1970s (1). The quality and quantity of radiotherapy varied a ...Missing: 1900s risk
  145. [145]
    From the humble wart to HPV: a fascinating story throughout centuries
    Aug 17, 2010 · Concerning the etymology, the term condyloma derives from ancient Greek and means a round tumor and acuminata comes from the Latin for “sharp ...
  146. [146]
    The history of cryosurgery - PMC - NIH
    He designed his own equipment, consisting of a waterproof cushion applied to the skin, two long flexible tubes to convey water to and from the affected part and ...
  147. [147]
    Treatment of genital warts with an immune-response modifier ...
    Topical 5% imiquimod cream appears to have a significant therapeutic effect in the treatment of external genital warts.
  148. [148]
    The novel treatment of children with viral warts using microwave ...
    Sep 18, 2023 · This study provides evidence that microwave therapy can be used for the treatment of warts in paediatric patients.